TY  - CONF
AU  - Pivi, M.T.F.
AU  - Adler, L.
AU  - De Franco, A.
AU  - Farinon, F.
AU  - Gambino, N.
AU  - Guidoboni, G.
AU  - Kowarik, G.
AU  - Kronberger, M.
AU  - Kurfürst, C.
AU  - Lau, H.T.
AU  - Myalski, S.
AU  - Nowak, S.
AU  - Penescu, L.C.
AU  - Schmitzer, C.
AU  - Strašík, I.
AU  - Urschütz, P.
AU  - Wastl, A.
ED  - Boland, Mark
ED  - Tanaka, Hitoshi
ED  - Button, David
ED  - Dowd, Rohan
ED  - Schaa, Volker RW
ED  - Tan, Eugene
TI  - Status of the Carbon Commissioning and Roadmap Projects of the MedAustron Ion Therapy Center Accelerator
J2  - Proc. of IPAC2019, Melbourne, Australia, 19-24 May 2019
CY  - Melbourne, Australia
T2  - International Particle Accelerator Conference
T3  - 10
LA  - english
AB  - The synchrotron-based MedAustron Particle Therapy Accelerator MAPTA located in Austria, delivers proton beams for medical treatment in the energy range 62-252 MeV/n since the year 2016 and is in preparation to provide C⁶⁺ carbon ions in the range 120-400 MeV/n to two of the three clinically used ion therapy irradiation rooms. In addition, carbon and proton beams, the latter with up to 800 MeV, will be provided to a fourth room dedicated to research. After beam generation and pre-acceleration to 7MeV, a 77m long synchrotron accelerates particles up to the requested energy for clinical treatment. A third-order resonance extraction method is used to extract the particles from the synchrotron in a slow controlled process and then transfer the particles to the 4 irradiation rooms with a spill time of 0.1-10 seconds to facilitate the control of the delivered radiation dose during clinical treatments. Presently, proton beams are delivered to the horizontal and vertical beam lines of three rooms. Commissioning of the accelerator with carbon ions has been completed for one beam line. In parallel, the installation of the beam line magnets for the proton Gantry is ongoing. A review of the accelerator and the status of the carbon commissioning, ongoing in parallel with clinical operations, and an outlook to future roadmap projects are presented.
PB  - JACoW Publishing
CP  - Geneva, Switzerland
SP  - 3404
EP  - 3407
KW  - proton
KW  - MMI
KW  - synchrotron
KW  - injection
KW  - extraction
DA  - 2019/06
PY  - 2019
SN  - 978-3-95450-208-0
DO  - DOI: 10.18429/JACoW-IPAC2019-THXXPLS1
UR  - http://jacow.org/ipac2019/papers/thxxpls1.pdf
ER  - 

TY  - CONF
AU  - Pasternak, J.
AU  - Ettlinger, O.
AU  - Hunt, C.
AU  - Kurup, A.
AU  - Lau, H.T.
AU  - Long, K.R.
AU  - Najmudin, Z.
AU  - Pozimski, J.K.
ED  - Boland, Mark
ED  - Tanaka, Hitoshi
ED  - Button, David
ED  - Dowd, Rohan
ED  - Schaa, Volker RW
ED  - Tan, Eugene
TI  - Design of LhARA - Laser Hybrid Accelerator for Radiobiological Applications
J2  - Proc. of IPAC2019, Melbourne, Australia, 19-24 May 2019
CY  - Melbourne, Australia
T2  - International Particle Accelerator Conference
T3  - 10
LA  - english
AB  - Recent developments of using lasers interacting with targets for the creation of ion beams offer a possibility to provide beams for radiobiology research. This research aims to precisely study the radiobiological effectiveness of charged particles on various cultures of cells, which is essential to inform next generation hadron therapy treat-ment plans. The Laser hybrid Accelerator for Radiobio-logical Applications (LhARA) has been proposed to use a laser driven beam, which will be captured and focused using Gabor Lenses. The beam will be then energy and momentum selected to create a beam for in-vitro cells studies or sent to a post-accelerator ring to create beam for in-vivo studies. The optical design of LhARA is pre-sented in this paper.
PB  - JACoW Publishing
CP  - Geneva, Switzerland
SP  - 3578
EP  - 3580
KW  - proton
KW  - laser
KW  - focusing
KW  - target
KW  - experiment
DA  - 2019/06
PY  - 2019
SN  - 978-3-95450-208-0
DO  - DOI: 10.18429/JACoW-IPAC2019-THPGW001
UR  - http://jacow.org/ipac2019/papers/thpgw001.pdf
ER  -